COMING SOON
U'thumim Genetics™: Next generation at-issues early warning health data detector: Time is brain, a stitch in time saves nine.
About Cellmolecules
Cellmolecules Scientific Canada Inc is a global leader in providing platform that enhance scientific communication and interactions thereby creating environment that encourage world-class or leading scientists and experts to collaborate more to drive innovations in solving emerging challenges across the globe. We set a stage for better communication of science and technology through number of ways such as holding scientific conferences, workshops and short training courses, symposiums, seminars and publishing Open Access peer-reviewed journals across the broad spectrum of science, especially basic and medical sciences. We hope to reach out to today and future noble prize holders in science and make young scientists have better access to their experience.
U'thumim Genetics™: (of Cellmolecules Scientific Canada Inc)
Exome specific DNA diagnostic sequencing and at-home testing devices and Kits, that combines relevant data, personal health information data output from AI based library, and other throughput technologies, to accurately detect a problem early enough when there is opportunity to prevent it, and fast-track healthy living and life style adjustment, with affordable cost for every family, focusing on Oncology, neglected diseases, paediatrics, microbial monitoring and reproductive health, that revolutionize personalized medicine, and proactive health.
Indeed, this is a next generation technology using a free subscription app model, clients would order test device, and have option to use AI enabled technology and GPS. System integrated to the online order system. This automatically dispatch a trackable kit, and or a phlebotomist to the home of the client, if this add-on service is also paid for, otherwise, the client receives the kit within 24-48 hours. A standby Telehealth is also available.
Leadership
Dr. Maxwell Omabe, Founder & CEO
Dr. Omabe is a business leader, and a Clinical Pathologist, board certified with Royal College of Pathologist, American Board of Clinical Chemistry, and Canadian Society for Medical Laboratory Sciences, and Fellow of the Association of Diagnostics and Laboratory Medicine. He spent 18 years in Academia as Associate Professor in Medical Genetics and Chemical Pathology, and Immunology.
Dr. Omabe completed Postdoctoral Training at University of Saskatchewan, a postgraduate professional Business degree at University of Toronto 2023, worked at many hospitals, and authored textbooks in Diagnostic Genetics and Chemical Pathology.
Express Interest
Interested in Investing? Join our Waitlist to get updates about our upcoming raise on Equivesto.
Disclaimer: This content is provided for informational purposes only. This is not a solicitation to purchase securities. The content on this page may contain forward looking statements that have not and cannot be verified, and past results are not indicators of future performance. The information on this page has not been verified by Equivesto Canada Inc. Prior to any securities being offered relating to this entity on Equivesto's platform, Equivesto Canada Inc. will complete its due diligence and Know Your Product process to confirm the eligibility of any securities for purchase by investor clients through the Equivesto platform. Equivesto Canada Inc. maintains the right to approve any investor client or issuer client prior to being given access to the Equivesto platform. Providing your information on this page does not guarantee you the ability or right to purchase securities in the future, either via the Equivesto platform or from the company listed here. There is no guarantee that this company will offer securities via the Equivesto platform in the future.